← FDA Drug Approvals (Drugs@FDA)

BEXAROTENE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2014-08-12

Drug application

FDA Application #

ANDA203174

Application type

Abbreviated New Drug Application (Generic)

Brand name

BEXAROTENE

Generic name

BEXAROTENE

Active ingredients

BEXAROTENE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

BIONPHARMA

Manufacturer

Mylan Pharmaceuticals Inc.

First approval

2014-08-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown